Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma
Gayle, Sophia, Landrette, Sean, Beeharry, Neil, Conrad, Chris, Hernandez, Marylens, Beckett, Paul, Ferguson, Shawn M., Mandelkern, Talya, Zheng, Meiling, Xu, Tian, Rothberg, Jonathan, Lichenstein, HenVolume:
129
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2016-09-736892
Date:
March, 2017
File:
PDF, 9.53 MB
english, 2017